Skip to content

TRADE ONLY | APPLY TODAY

  • Products
    • Skin Boosters
    • Dermal Fillers
    • Fat Dissolvers
    • Mesotherapy/Polynucleotides
  • Trade Application
  • Contact
Log in
  • Twitter
  • Facebook
  • Instagram
  • TikTok
Well Being Pharmacy
  • Products
    • Skin Boosters
    • Dermal Fillers
    • Fat Dissolvers
    • Mesotherapy/Polynucleotides
  • Trade Application
  • Contact
Log in Cart
Access Denied
IMPORTANT! If you’re a store owner, please make sure you have Customer accounts enabled in your Store Admin, as you have customer based locks set up with EasyLockdown app. Enable Customer Accounts
Skip to product information
1 / of 1

Azzalure

Azzalure 1 x 125 Speywood Units

Azzalure 1 x 125 Speywood Units

Regular price £137.00
Regular price Sale price £137.00
Unit price /  per 
Sale Sold out

  • Dosage: 2 x 125 IU

1. Name of the Medicinal Product
Azzalure, 125 Speywood units, powder for solution for injection
 
2. Qualitative and Quantitative Composition 

  • Botulinum toxin type A* Quantity corresponding to 125 Speywood units (U)** for one vial.
  • *Clostridium botulinum toxin A haemagglutinin complex
  • ** The Speywood units of Azzalure are specific to the preparation and are not interchangeable with other preparations of botulinum toxin. 

 
3. Pharmaceutical Form

  • Powder for solution for injection. 
  • The powder is white.

          
4. Clinical Particulars 
 
4.1 Therapeutic Indications 
Azzalure is indicated for the temporary improvement in the appearance of moderate to severe:

  • Glabellar lines (vertical lines between the eyebrows) seen at maximum frown and/or
  • Lateral canthal lines (crow's feet lines) seen at maximum smile in adult patients under 65 years, when the severity of these lines has an important psychological impact on the patient. 

 
4.2 Posology and Method of Administration 
Posology: Botulinum toxin units are different depending on the medicinal products. The Speywood units of Azzalure are specific to the preparation and are not interchangeable with other preparations of botulinum toxin. 
 
Paediatric Population: The safety and efficacy of Azzalure in individuals aged up to 18 years have not been established. The use of Azzalure is not recommended in subjects under 18 years. 
 
Method of Administration:

  • Azzalure should only be administered by a specialised practitioner with appropriate qualifications and expertise in this treatment and having the required equipment, in accordance with national guidelines.
  • Once reconstituted, Azzalure should only be used to treat a single patient, during a single session.
  • For instructions on reconstitution of the medicinal product before administration, see section 6.6.
  • Remove any make-up and disinfect the skin with a local antiseptic.
  • Intramuscular injections should be performed using a sterile suitable gauge needle.
  • The treatment interval depends on the individual patient's response after assessment. Treatment interval with Azzalure should not be more frequent than every three months. 

Recommended Injection Points for Glabellar Lines and Lateral Canthal Lines:

  • Detailed instructions on injection points for both glabellar and lateral canthal lines are provided. 
     

4.3 Contraindications

  • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1
  • Presence of infection at the proposed injection sites
  • Presence of myasthenia gravis, Eaton Lambert Syndrome or amyotrophic lateral sclerosis. 

 
4.4 Special Warnings and Precautions for Use

  • Various precautions for use are listed, including the need to avoid injecting into blood vessels, the caution when used in patients with pre-existing neuromuscular disorders, the possibility of local and distant spread of toxin effect, and the risk of antibody formation.
  • Detailed guidance is provided for facial anatomy assessment before administering Azzalure, and precautions for injection in the presence of inflammation or weakness. 

 
4.5 Interaction with Other Medicinal Products and Other Forms of Interaction

  • Information on concomitant treatment with aminoglycosides and other agents interfering with neuromuscular transmission.
  • Please note that the content provided is a comprehensive summary of the original text provided, organized into sections for clarity and readability. Always refer to the original source or official medical documents for the most accurate and up-to-date information

Additional information
Contents | 2 x 125 units
Cold Chain | Cold
Storage Conditions | 2-8 °C
Legal Category | POM
Form | Vial
Prescription Only | Yes

 

Delivery information

All orders placed before 1pm (Monday – Thursday) will be sent for Next Day delivery with DPD (excluding Bank Holidays), subject to stock availability. Friday orders will be dispensed on Monday for delivery on Tuesday. Deliveries to certain areas of Scotland, Northern Ireland and some remote areas of England cannot be guaranteed next day delivery. All items must be signed for as proof of delivery.

Delivery costs are a flat rate of £5.99.

View full details
Azzalure 1 x 125 Speywood Units
Invalid password
Enter

Medicines are dispensed by our registered pharmacy, supervised by our superintendent pharmacist Soonick Seow, registration number 2065608. You can check the pharmacists register here. Our premise is a pharmacy and has been inspected by the General Pharmaceutical Council (GPhC). We supply POM medicines dispensed by qualified pharmacists. Our premises approval number is: 1107924. You can check our approval on the GPhC website.

Wellbeing Pharmacy, Greenhill Lane, Riddings, Alfreton, Derbyshire, DE55 1LU. T: 02080886660 . E: info@wellbeing-aesthetics.com

The pharmacy’s GPhC registration number: 1107924
Superintendent pharmacist: Soonick Seow, registration number: 2065608

Subscribe to our emails

  • Facebook
  • Instagram
  • TikTok
  • Twitter
Payment methods
    © 2025, Well Being Pharmacy
    • Refund policy
    • Privacy policy
    • Terms of service
    • Shipping policy
    • Choosing a selection results in a full page refresh.
    • Opens in a new window.